Sanara MedTech (SMTI) Competitors $30.70 -0.32 (-1.02%) As of 02:12 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SMTI vs. KMTS, BLFS, PLSE, FNA, MDXG, INMD, ESTA, SIBN, EMBC, and IRMDShould you be buying Sanara MedTech stock or one of its competitors? The main competitors of Sanara MedTech include Kestra Medical Technologies (KMTS), BioLife Solutions (BLFS), Pulse Biosciences (PLSE), Paragon 28 (FNA), MiMedx Group (MDXG), InMode (INMD), Establishment Labs (ESTA), SI-BONE (SIBN), Embecta (EMBC), and Iradimed (IRMD). These companies are all part of the "medical equipment" industry. Sanara MedTech vs. Kestra Medical Technologies BioLife Solutions Pulse Biosciences Paragon 28 MiMedx Group InMode Establishment Labs SI-BONE Embecta Iradimed Sanara MedTech (NASDAQ:SMTI) and Kestra Medical Technologies (NASDAQ:KMTS) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their community ranking, media sentiment, earnings, analyst recommendations, institutional ownership, dividends, risk, valuation and profitability. Do institutionals & insiders hold more shares of SMTI or KMTS? 8.1% of Sanara MedTech shares are held by institutional investors. 54.1% of Sanara MedTech shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Is SMTI or KMTS more profitable? Kestra Medical Technologies has a net margin of 0.00% compared to Sanara MedTech's net margin of -10.71%. Kestra Medical Technologies' return on equity of 0.00% beat Sanara MedTech's return on equity.Company Net Margins Return on Equity Return on Assets Sanara MedTech-10.71% -19.86% -10.91% Kestra Medical Technologies N/A N/A N/A Does the media favor SMTI or KMTS? In the previous week, Sanara MedTech had 19 more articles in the media than Kestra Medical Technologies. MarketBeat recorded 20 mentions for Sanara MedTech and 1 mentions for Kestra Medical Technologies. Kestra Medical Technologies' average media sentiment score of 0.67 beat Sanara MedTech's score of 0.33 indicating that Kestra Medical Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sanara MedTech 5 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Kestra Medical Technologies 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger valuation & earnings, SMTI or KMTS? Kestra Medical Technologies has lower revenue, but higher earnings than Sanara MedTech. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSanara MedTech$86.67M3.15-$4.30M-$1.34-22.91Kestra Medical Technologies$52.64M22.28N/AN/AN/A Does the MarketBeat Community believe in SMTI or KMTS? Sanara MedTech received 19 more outperform votes than Kestra Medical Technologies when rated by MarketBeat users. However, 71.43% of users gave Kestra Medical Technologies an outperform vote while only 61.54% of users gave Sanara MedTech an outperform vote. CompanyUnderperformOutperformSanara MedTechOutperform Votes2461.54% Underperform Votes1538.46% Kestra Medical TechnologiesOutperform Votes571.43% Underperform Votes228.57% Do analysts recommend SMTI or KMTS? Sanara MedTech presently has a consensus price target of $49.50, indicating a potential upside of 61.21%. Kestra Medical Technologies has a consensus price target of $27.50, indicating a potential upside of 20.40%. Given Sanara MedTech's stronger consensus rating and higher probable upside, equities research analysts clearly believe Sanara MedTech is more favorable than Kestra Medical Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sanara MedTech 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Kestra Medical Technologies 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.83 SummarySanara MedTech and Kestra Medical Technologies tied by winning 7 of the 14 factors compared between the two stocks. Get Sanara MedTech News Delivered to You Automatically Sign up to receive the latest news and ratings for SMTI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SMTI vs. The Competition Export to ExcelMetricSanara MedTechSurgical appliances & supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$272.91M$9.46B$5.35B$8.44BDividend YieldN/A1.61%5.21%4.11%P/E Ratio-31.0220.7926.9119.77Price / Sales3.1563.84390.06119.10Price / CashN/A19.6738.2534.62Price / Book5.885.096.794.52Net Income-$4.30M$284.66M$3.23B$248.23M7 Day Performance-0.57%-0.81%1.99%0.77%1 Month Performance1.94%1.83%11.45%13.45%1 Year Performance1.40%-21.63%17.35%7.67% Sanara MedTech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SMTISanara MedTech1.7625 of 5 stars$30.71-1.0%$49.50+61.2%-1.6%$272.91M$86.67M-31.0260Analyst RevisionKMTSKestra Medical TechnologiesN/A$23.58+4.0%$27.50+16.6%N/A$1.21B$52.64M0.00300Positive NewsGap UpBLFSBioLife Solutions2.4285 of 5 stars$23.89+2.6%$31.17+30.5%+1.9%$1.13B$87.76M-22.54440News CoveragePositive NewsAnalyst DowngradeGap UpPLSEPulse Biosciences0.9477 of 5 stars$16.79-1.6%N/A+77.8%$1.13B$700,000.000.00140Gap UpFNAParagon 28N/A$13.11+0.1%$12.75-2.7%+75.2%$1.10B$256.18M-17.71343,000High Trading VolumeMDXGMiMedx Group3.8261 of 5 stars$7.25+2.8%$12.50+72.4%-13.2%$1.07B$352.38M13.18870Positive NewsINMDInMode3.5049 of 5 stars$15.00+3.8%$18.54+23.6%-24.2%$1.04B$392.41M6.38480Positive NewsESTAEstablishment Labs2.8853 of 5 stars$34.58+1.9%$57.40+66.0%-34.0%$997.50M$170.24M-13.40960Analyst DowngradeGap UpSIBNSI-BONE3.583 of 5 stars$18.78+1.6%$22.50+19.8%+36.1%$798.70M$176.60M-20.41350Insider TradeEMBCEmbecta4.1472 of 5 stars$12.41+3.7%$20.33+63.8%-9.8%$721.44M$1.11B12.411,900Positive NewsAnalyst UpgradeHigh Trading VolumeIRMDIradimed4.8919 of 5 stars$52.57+1.4%$72.00+37.0%+20.6%$659.40M$75.15M35.05110Gap Up Related Companies and Tools Related Companies Kestra Medical Technologies Competitors BioLife Solutions Competitors Pulse Biosciences Competitors Paragon 28 Competitors MiMedx Group Competitors InMode Competitors Establishment Labs Competitors SI-BONE Competitors Embecta Competitors Iradimed Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SMTI) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredThe Collapse Has Already Started — Your 401(k) Is NextThere's a major heist happening on American wealth in real time. Except this one doesn't involve masks or v...American Hartford Gold | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sanara MedTech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sanara MedTech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
